While several proteins demonstrated enrichment, IGFBP2 was chosen for further analysis due to higher enrichment levels in SHH MB, its known roles in regulation of tumorigenicity and metastasis in other cancers, and lack of conclusive previous studies in medulloblastoma. The gene discussed is IGFBP2; the disease is cancer.